GlassScriptPhysician profile
Keith W Harrison
NPI 1962477349
$4,400.58
in general payments reported to CMS, 2019-2025
38 companies · $750 in 2025
The $750 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $919 · 2020: $405 · 2021: $186 · 2022: $605 · 2023: $735 · 2024: $800 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,243 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,242.70 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $689.03 | 2019-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $359.91 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $351.07 | 2019-2025 | Farxiga, Lokelma, Airsupra |
| Abbott Laboratories | $337.63 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Lilly USA, LLC | $327.84 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $322.64 | 2019-2025 | |
| Glaxosmithkline, LLC. | $274.41 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $219.09 | 2019-2025 | Evenity, Prolia, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.76 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Mannkind Corporation | $177.10 | 2019-2025 | Afrezza |
| Sanofi-Aventis U.S. LLC | $162.38 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $99.81 | 2019-2024 | |
| Allergan, INC. | $85.98 | 2019-2020 | |
| Dexcom, INC. | $81.32 | 2021-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.14 | 2020-2025 | Xifaxan |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.